AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 36 filers reported holding AC IMMUNE SA in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $20 | -99.0% | 10 | -97.6% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 420 | -52.3% | 0.00% | – |
| Q2 2022 | $3,000 | -80.0% | 881 | -76.5% | 0.00% | – |
| Q1 2022 | $15,000 | +15.4% | 3,754 | +37.3% | 0.00% | – |
| Q4 2021 | $13,000 | -80.3% | 2,735 | -72.3% | 0.00% | – |
| Q3 2021 | $66,000 | +94.1% | 9,878 | +132.6% | 0.00% | – |
| Q2 2021 | $34,000 | +750.0% | 4,247 | +569.9% | 0.00% | – |
| Q1 2021 | $4,000 | -98.8% | 634 | -99.1% | 0.00% | – |
| Q3 2020 | $327,000 | +6440.0% | 67,065 | +8842.0% | 0.00% | – |
| Q1 2020 | $5,000 | -50.0% | 750 | -36.8% | 0.00% | – |
| Q4 2019 | $10,000 | +150.0% | 1,187 | +58.3% | 0.00% | – |
| Q3 2019 | $4,000 | -84.6% | 750 | -84.2% | 0.00% | – |
| Q2 2019 | $26,000 | – | 4,738 | +52544.4% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 9 | -99.7% | 0.00% | – |
| Q4 2018 | $30,000 | – | 3,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $29,714,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 100,000 | $400,000 | 0.19% |
| Artal Group S.A. | 1,000,000 | $4,000,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,062,462 | $4,250,000 | 0.13% |
| Kingsbury Capital Investment Advisors LLC | 18,975 | $76,000 | 0.08% |
| EcoR1 Capital, LLC | 485,005 | $1,940,000 | 0.06% |
| Virtus ETF Advisers LLC | 31,014 | $124,000 | 0.06% |
| Eversept Partners, LP | 124,589 | $498,356 | 0.04% |
| COHEN LAWRENCE B | 12,850 | $51,000 | 0.03% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 50,000 | $200,000 | 0.02% |